Skip to main content
Commentary

Ensuring access to medications in the US during the COVID-19 pandemic.

Alexander GC, Qato DM. Ensuring access to medications in the US during the COVID-19 pandemic. JAMA. 2020;324(1):31-32. doi:10.1001/jama.2020.6016.

Save
Print
May 6, 2020
Alexander GC, Qato DM. JAMA. 2020;324(1):31-32.
View more articles from the same authors.

The COVID-19 pandemic has raised concerns about the pharmaceutical supply chain, from overseas manufacturing to medication distribution within the United States. This commentary presents several emergency response and preparedness measures for policymakers, pharmaceutical distributors and pharmacies to prepare for drug shortages and demand surges. Suggested measures include developing an “essential medicines” strategy, using allocation strategies that prevent stockpiling and drug shortages and expanding capacity for mail-order and home delivery.

Save
Print
Cite
Citation

Alexander GC, Qato DM. Ensuring access to medications in the US during the COVID-19 pandemic. JAMA. 2020;324(1):31-32. doi:10.1001/jama.2020.6016.

Related Resources From the Same Author(s)
Related Resources